“…In our previous studies on the anticancer screening of various 1,2,3-triazoles, compounds based on 1,2,3-triazolyl-4carboxamide scaffolds possessed the highest antiproliferative activity (Shyyka et al, 2019;Pokhodylo et al, 2013Pokhodylo et al, , 2014. Furthermore, a series of 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing the 1,2,3-triazole-4carboxamide moiety have been evaluated against c-Met kinase and five typical cancer cell lines (A549, H460, HT-29, MKN-45 and U87MG) and exhibited moderate to excellent ISSN 2056-9890 antiproliferative activity (Zhou et al, 2014).…”